DEVELOP
Growth innovative SMBs action plan
« Lunch Break Partnering »
Launched in 2008, the “Lunch Break Partnering” are an informal opportunity to share ideas on a given topic and to network at lunchtime.
This type of event is held once a month and is attended by an average of 25 participants from SMBs
The following topics have been treated in 2008-2009 :
- Financing Innovation,
- Access to European programs for SMBs, Oseo and international development
- How to manage and optimize your IP,
- Taxation as part of your innovation strategy,
- The French Research Tax Credit (CIR),
- The consortium agreements,
- the SMBs’ helps for the international development,
- evolution of market rates and exchange,
- the life of the employment contract,
- The Biotech Company Business Models,
- The laboratories of microbiological safety, design, implementation, and daily management
- The Oséo ISI financing program,
- Programming and installation of ANR
- The Lunch Break Partnering’s program
Calendar of the 2010 Lunch Break Partnering:
- January : The Intellectual Property
- February : Lyonbiopole actions to support the International development of SMBs
- March : Regulatory affairs and Phamarcoeconomics
- April : Industrial espionage
- June : OSEO programs to support companies abroad
Coming events:
- July : biosecurity laboratory
- September : Taxation of R&D funding
- October : Research Tax Credit (CIR)
- November : ANR calls
- December : Private funding
They speak about...
« As part of its mission to support the economic development of SMBs, Lyonbiopole's staff is mobilized to ensure the success of this daylong event dedicated to funding. The event, which featured roundtable discussions and presentations, allowed for interactive dialog between the participants, the aim being to promote contacts between managers of SMBs and private and institutional investors. The strengthening of SMBs' equity is an essential condition to set up increasingly ambitious R&D projects, for their competitiveness worldwide and for their credibility in the eyes of major industrial groups. »
Thierry Abribat
Alizée Pharma - President